News & Views

  • Trials to Test Potential for Immunotherapy Technology

Trials to Test Potential for Immunotherapy Technology

Oct 07 2019 Read 641 Times

Sydney-based Immutep Ltd, developers of immunotherapy treatments for cancer and autoimmune diseases, is to receive a milestone payment from GSK of GB £4 million (approx AU $7.39 million) related to the first patient being dosed in GSK’s Phase II clinical trial evaluating GSK2831781 in ulcerative colitis. 

GSK2831781 is derived from Immutep’s IMP731 antibody, a depleting anti-LAG antibody technology that was exclusively licensed to GSK. Under the terms of the agreement, the Australian biotech is eligible to receive up to GB £64 million (approx AU $118.17 million) in developmental milestone payments as well as single-digit tiered royalties, if commercialisation stages are reached. GSK is responsible for all costs associated with the clinical development and the commercialisation process.

Immutep CEO Marc Voigt, said: “It is very encouraging to see GSK advancing their product candidate in a phase II clinical trial for ulcerative colitis, further validating LAG-3 as a potential target for therapeutics in autoimmune diseases. These partner milestone payments are an important source of non-dilutive funding to the company and this capital will be deployed to further advance our extensive development programs.”

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

Labmate UK & Ireland April 2020

April 2020

In This Edition Articles - Export experts talk Corona Virus - Automated cell counting shouldn’t cost the earth Laboratory Products - Spectrophotometer Linearity Validation - Analysi...

View all digital editions

Events

Laborama 2020 - ONLINE EVENT

Jun 11 2020 Brussels, Belgium

HPLC 2020 - EVENT CANCELLED

Jun 20 2020 San Diego, CA, USA

MedtecLIVE - ONLINE EVENT

Jun 30 2020 Nuremberg, Germany

Korea Lab 2020 - NEW DATES

Jul 27 2020 Kintex, South Korea

M&M 2020 - ONLINE EVENT

Aug 02 2020 Milwaukee, Wisconsin, USA

View all events